Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
Meng‐Xin Tian(Sun Yat-sen University), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Pei‐Yun Zhou(Fudan University), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Wei‐Ren Liu(Chung Yuan Christian University), Wan Yee Lau(Chinese University of Hong Kong), Zhi Dai(Ministry of Education of the People's Republic of China), Jian Zhou(Shenzhen University Health Science Center), Chenyang Tao(Ministry of Education of the People's Republic of China), Han Wang(Hebei Agricultural University), Jia Fan(Nanjing Tech University), Lei Jin(Zhejiang Chinese Medical University), Zheng Tang(Ministry of Education of the People's Republic of China), Yuan Fang(Guangzhou University of Chinese Medicine), Xi‐Fei Jiang(Sun Yat-sen University), Shuang‐Jian Qiu(Fudan University), Zhen‐Bin Ding(Fudan University), Yufu Zhou(Central South University), Yuan‐Fei Peng(Fudan University)
Cited by 44
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828